Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04398784 · ClinicalTrials.gov registry record · NA
Effect of Whole Blueberry Powder Consumption on Depression in a Central Louisiana Population
A NA study of Depression and Inflammation, sponsored by Louisiana State University, Baton Rouge.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT04398784: Completed NA study of Depression and Inflammation, sponsored by Louisiana State University, Baton Rouge.
NCT04398784 is a NA study of Depression and Inflammation that has completed, run by Louisiana State University, Baton Rouge. The registered enrollment target is 45 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04398784, a NA study of Depression and Inflammation, has completed, sponsored by Louisiana State University, Baton Rouge.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot study aims to measure the effects of an intervention of 22.5 grams of freeze-dried whole blueberry powder in water drunk daily. Measures are on outcomes of depression, biological markers of inflammation and oxidative stress, and microbial populations in the intestines.
Primary Outcome
A brief (10-Item) behavioral survey for assessing clinical depression symptoms and severity; can confirm a Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) diagnosis of depression. The scale spans 0-5 to score "How much of the time..." with 0=at no time and 5=all the time; the higher the score, the more severe the depressive symptom.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Freeze Dried Blueberry Powder - 71717
- DIETARY_SUPPLEMENT USHBC Blueberry Placebo Formula #114
Study Locations (2)
Louisiana
- Cottonport Family Clinic - Cottonport
- Marksville Family Clinic - Marksville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2019-11-26 |
| Phase | NA |
What the finished NCT04398784 record still lists
NCT04398784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Freeze Dried Blueberry Powder - 71717 is the first listed.
NCT04398784 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT04398784 about?
NCT04398784 is a clinical study titled "Effect of Whole Blueberry Powder Consumption on Depression in a Central Louisiana Population". This pilot study aims to measure the effects of an intervention of 22.5 grams of freeze-dried whole blueberry powder in water drunk daily. Measures are on outcomes of depression, biological markers of inflammation and oxidative stress, and microbial populations in the intestines.
What is the current status of trial NCT04398784?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-04-15. Estimated completion is 2019-11-26.
What conditions does trial NCT04398784 study?
This clinical trial studies the following conditions: Depression, Inflammation, Depression, Anxiety.
What interventions are being tested in trial NCT04398784?
The interventions under investigation include: Freeze Dried Blueberry Powder - 71717 (DIETARY_SUPPLEMENT), USHBC Blueberry Placebo Formula #114 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04398784?
This trial is sponsored by Louisiana State University, Baton Rouge, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04398784 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04398784's enrollment target sits among peer trials
45 488th of 679 higher than 186 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy